Zhejiang Xinguang Pharmaceutical Co Ltd (300519) — Strategic Asset Allocation Index
Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has a Strategic Asset Allocation Index of 13.4% as of June 2023. Strategic assets (PP&E of CN¥109.82 Million plus long-term investments of CN¥-) total CN¥109.82 Million, measured against net assets of CN¥817.77 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Zhejiang Xinguang Pharmaceutical Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Zhejiang Xinguang Pharmaceutical Co Ltd Strategic Asset Allocation Index (2011–2022)
This chart shows how Zhejiang Xinguang Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 13.4%, representing strategic assets of CN¥109.82 Million against net assets of CN¥817.77 Million CNY. See financial agility of Zhejiang Xinguang Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Zhejiang Xinguang Pharmaceutical Co Ltd stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 13.4% | CN¥114.88 Million | CN¥114.88 Million | CN¥- | CN¥858.89 Million | ▼ -0.2 pp |
| 2021 | 13.6% | CN¥114.68 Million | CN¥114.68 Million | CN¥- | CN¥846.22 Million | ▼ -0.1 pp |
| 2020 | 13.6% | CN¥112.84 Million | CN¥112.84 Million | CN¥- | CN¥826.94 Million | ▼ -1.9 pp |
| 2019 | 15.6% | CN¥124.47 Million | CN¥124.47 Million | CN¥- | CN¥799.71 Million | ▼ -4.4 pp |
| 2018 | 20.0% | CN¥150.28 Million | CN¥123.58 Million | CN¥26.71 Million | CN¥753.26 Million | ▼ -0.1 pp |
| 2017 | 20.0% | CN¥141.27 Million | CN¥113.92 Million | CN¥27.35 Million | CN¥705.81 Million | ▲ +1.5 pp |
| 2016 | 18.6% | CN¥118.85 Million | CN¥90.54 Million | CN¥28.31 Million | CN¥640.46 Million | ▼ -15.5 pp |
| 2015 | 34.0% | CN¥105.26 Million | CN¥75.42 Million | CN¥29.84 Million | CN¥309.35 Million | ▲ +7.8 pp |
| 2014 | 26.2% | CN¥65.32 Million | CN¥65.32 Million | CN¥- | CN¥249.00 Million | ▲ +2.1 pp |
| 2013 | 24.2% | CN¥48.81 Million | CN¥48.81 Million | CN¥- | CN¥201.97 Million | ▼ -9.3 pp |
| 2012 | 33.5% | CN¥47.47 Million | CN¥47.47 Million | CN¥- | CN¥141.62 Million | ▼ -20.3 pp |
| 2011 | 53.8% | CN¥56.14 Million | CN¥56.14 Million | CN¥- | CN¥104.32 Million | — |